Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Development of improved adenosine deaminase retroviral vectors
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Development of improved adenosine deaminase retroviral vectors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Retroviral Vector
100%
Adenosine Deaminase
100%
Myeloproliferative Neoplasms
38%
Sarcoma
38%
Virus
30%
Long Terminal Repeat
30%
Clinical Trials
7%
Virus Vector
7%
Lymphohaematopoietic
7%
Supernatant
7%
Peripheral Blood Mononuclear Cells
7%
Enzyme Activity
7%
Severe Combined Immunodeficiency
7%
Vector Design
7%
Performance Improvement
7%
T Cell Lines
7%
Neomycin Phosphotransferase II (npt II)
7%
Immunocompromised Patients
7%
Moloney murine Leukemia Virus
7%
Virus Envelope
7%
B Cell Lines
7%
RD114
7%
Feline
7%
Endogenous Virus
7%
Gibbon Ape Leukemia Virus
7%
Selectable Marker
7%
Adenosine Deaminase Activity
7%
Packaging Cell
7%
Immunology and Microbiology
Retrovirus Vector
100%
Adenosine Deaminase
100%
Sarcoma Virus
35%
Long Terminal Repeat
28%
Cell Line
14%
Promoter Region
7%
T Cell
7%
B Cell
7%
Enzyme Activity
7%
Viral Vector
7%
Moloney Murine Leukemia Virus
7%
Viral Envelope
7%
Endogenous Virus
7%
Severe Combined Immunodeficiency
7%
Gibbon Ape Leukemia Virus
7%
Peripheral Blood Mononuclear Cell
7%